Literature DB >> 30006019

Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors.

Debangshu Samanta1, Gregg L Semenza2.   

Abstract

Cancer cells are characterized by high metabolic demand. The substrates in demand include oxygen, glucose, glutamine and lipids. Oxygen serves as a key substrate in cellular metabolism and bioenergetics. Hypoxia or low oxygen abundance is a common feature of the tumor microenvironment that occurs due to an imbalance in supply and demand. Many of the metabolic responses to hypoxia in both cancer cells and stromal cells are orchestrated by hypoxia-inducible factors (HIFs). In this review we summarize our current understanding of how HIFs modulate the metabolism of hypoxic cancer cells and immune cells, and how altered metabolism plays a role in cancer progression.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30006019     DOI: 10.1016/j.bbcan.2018.07.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  51 in total

1.  Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α.

Authors:  Shanshan Lin; Bo Zhu; Guozhi Huang; Qing Zeng; Chuhuai Wang
Journal:  Hum Cell       Date:  2018-11-30       Impact factor: 4.174

Review 2.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

Review 3.  Turning the Oxygen Dial: Balancing the Highs and Lows.

Authors:  Alan H Baik; Isha H Jain
Journal:  Trends Cell Biol       Date:  2020-05-05       Impact factor: 20.808

4.  Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier.

Authors:  Claire L Bensard; Dona R Wisidagama; Kristofor A Olson; Jordan A Berg; Nathan M Krah; John C Schell; Sara M Nowinski; Sarah Fogarty; Alex J Bott; Peng Wei; Katja K Dove; Jason M Tanner; Vanja Panic; Ahmad Cluntun; Sandra Lettlova; Christian S Earl; David F Namnath; Karina Vázquez-Arreguín; Claudio J Villanueva; Dean Tantin; L Charles Murtaugh; Kimberley J Evason; Gregory S Ducker; Carl S Thummel; Jared Rutter
Journal:  Cell Metab       Date:  2019-12-05       Impact factor: 27.287

Review 5.  HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer.

Authors:  Ellen C de Heer; Mathilde Jalving; Adrian L Harris
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 6.  Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.

Authors:  Pearl Lee; Navdeep S Chandel; M Celeste Simon
Journal:  Nat Rev Mol Cell Biol       Date:  2020-03-06       Impact factor: 94.444

Review 7.  A guide to plasma membrane solute carrier proteins.

Authors:  Mattia D Pizzagalli; Ariel Bensimon; Giulio Superti-Furga
Journal:  FEBS J       Date:  2020-09-18       Impact factor: 5.542

8.  Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice.

Authors:  Jasper A F Demandt; Kim van Kuijk; Thomas L Theelen; Elke Marsch; Sean P Heffron; Edward A Fisher; Peter Carmeliet; Erik A L Biessen; Judith C Sluimer
Journal:  Front Cell Dev Biol       Date:  2021-05-14

Review 9.  Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.

Authors:  Laura Bornes; Guillaume Belthier; Jacco van Rheenen
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

Review 10.  Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.

Authors:  Vittoria Infantino; Anna Santarsiero; Paolo Convertini; Simona Todisco; Vito Iacobazzi
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.